Genomtec

Genomtec R&D per Employee

R&D Spending per Employee of Genomtec (GMT.WA) as of Nov 10, 2026.

R&D per Employee

-PLN

Last updated:

R&D Spending per Employee of Genomtec is 2026 - PLN. R&D Spending per Employee of Genomtec was 2025 - PLN. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genomtec Stock analysis

What does Genomtec do? Genomtec SA generates revenue by researching and developing molecular diagnostic equipment, specifically focusing on the Genomtec ID mobile platform. This technology enables genetic diagnosis at the point of patient care, eliminating the need for complex laboratory workflows and qualified personnel. The platform is designed for use in primary care clinics, pharmacies, doctor’s offices, and hospital emergency departments. Genomtec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genomtec stock

On Eulerpool you can find the complete historical development of R&D Spending per Employee Genomtec since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Genomtec historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Genomtec

All Key Metrics — Genomtec